Bui L M, Keen C L, Dubick M A
Department of Nutrition, University of California, Davis 95616-8669, USA.
Toxicology. 1995 Apr 12;98(1-3):57-63. doi: 10.1016/0300-483x(95)91102-u.
Hypertension, cigarette smoking, and nicotine augment the clinical significance of other risk factors associated with cardiovascular diseases by mechanisms which are poorly understood. Since altered trace element metabolism and antioxidant status have also been implicated in these diseases, the present study investigated the interaction of nicotine treatment and hypertension on tissue trace element concentrations and select indices of antioxidant status. Spontaneously hypertensive (SHR) and normotensive Wistar Kyoto (WKY) rats were treated with nicotine, via a time release tablet at an average rate of 75 micrograms/h for 6 weeks. Systolic blood pressure in nicotine-treated SHRs was significantly higher at weeks 3 and 6 of treatment than in the SHR-controls. Blood pressure in WKY rats was not affected by nicotine. Plasma and liver iron concentrations in the nicotine-treated SHR were higher than the SHR-controls and the WKY groups. Nicotine treatment did not affect plasma and liver zinc and copper concentrations or liver manganese (Mn) concentrations. Plasma ceruloplasmin activity was increased by nicotine treatment in the SHRs. Liver Mn superoxide dismutase (MnSOD) activities and glutathione concentrations, and liver and heart glutathione reductase activities, were higher in both groups of SHRs than in the WKY groups. Red cell SOD activity in the nicotine-treated SHR was lower than in the SHR-controls. In summary, blood pressure increased more rapidly in the nicotine-treated SHRs compared to the controls. The marked effects on antioxidant status observed were attributable more to hypertension than to the nicotine treatment.
高血压、吸烟和尼古丁会通过一些尚不清楚的机制增强与心血管疾病相关的其他风险因素的临床意义。由于微量元素代谢改变和抗氧化状态改变也与这些疾病有关,因此本研究调查了尼古丁治疗与高血压对组织微量元素浓度和抗氧化状态的选定指标的相互作用。自发性高血压(SHR)大鼠和血压正常的Wistar Kyoto(WKY)大鼠通过缓释片以平均75微克/小时的速率接受尼古丁治疗,持续6周。在治疗的第3周和第6周,接受尼古丁治疗的SHR大鼠的收缩压显著高于SHR对照组。WKY大鼠的血压不受尼古丁影响。接受尼古丁治疗的SHR大鼠的血浆和肝脏铁浓度高于SHR对照组和WKY组。尼古丁治疗不影响血浆和肝脏锌、铜浓度或肝脏锰(Mn)浓度。尼古丁治疗使SHR大鼠的血浆铜蓝蛋白活性增加。两组SHR大鼠的肝脏锰超氧化物歧化酶(MnSOD)活性、谷胱甘肽浓度以及肝脏和心脏谷胱甘肽还原酶活性均高于WKY组。接受尼古丁治疗的SHR大鼠的红细胞SOD活性低于SHR对照组。总之,与对照组相比,接受尼古丁治疗的SHR大鼠血压升高更快。观察到的对抗氧化状态的显著影响更多归因于高血压而非尼古丁治疗。